Elliot's campaign

Meet Elliot 

Elliot is a happy and caring two-year-old who loves diggers and all things construction. He has the most infectious character and makes everyone around him belly laugh every day. 

He is happiest playing with his older sister, Callie, who he shares a magical bond with. Elliot is an incredibly determined little boy - something his parents, Adam and Emily, are so proud and thankful for. That determination has carried him through the toughest of times and will serve him well in the bright future they dream of for him. 

Despite everything he has faced at such a young age, Elliot never fails to amaze his parents with his positivity and strength. 

Elliot’s diagnosis 

In July 2024, aged just 15 months old, Elliot’s parents felt a lump in his leg. They took him to the GP and things quickly escalated into any parent’s worst nightmare. 

Elliot was diagnosed with stage 4 high-risk neuroblastoma, and life changed overnight. As a seemingly perfectly healthy baby, the diagnosis came as a huge shock. 

Neuroblastoma is an aggressive childhood cancer, and high-risk disease carries around a 50% chance of long-term survival at diagnosis. 

Elliot’s treatment 

Elliot quickly began an intensive treatment protocol lasting 16 months. By the age of two, he had faced 8 cycles of induction chemotherapy and two major surgeries to remove tumours — including a 10-hour operation to remove his primary abdominal tumour, and another which resulted in the removal of one of his hamstring muscles.

He then went on to endure high-dose chemotherapy with an autologous stem-cell transplant, followed by 13 cycles of proton beam radiotherapy and 6 months of immunotherapy.

The treatment has taken its toll and Elliot has experienced many complications along the way. Yet through it all, his spirit and strength have never wavered.

In November 2025, Elliot completed frontline treatment and proudly rang the bell at Royal Manchester Children’s Hospital. He then began DFMO, a clinical trial drug designed to help prevent relapse, which he will continue for the next two years.

The fear of relapse 

While Elliot has completed frontline treatment, he remains at very high risk of relapse. Relapsed high-risk neuroblastoma carries a devastating prognosis, and options available through the NHS are extremely limited.

In January 2026, Elliot became critically unwell and was admitted to intensive care. Shortly afterwards, a hard lump appeared on his arm, raising the terrifying possibility of relapse.

Thankfully, further investigations showed no sign of relapse. But the experience brought the family face to face with how quickly things can change, and just how few options exist if the cancer returns.

Families facing relapsed neuroblastoma are often catapulted overnight into a complex world of clinical trials and the urgent need to raise significant funds to access experimental treatments.

Why we are fundraising 

Adam and Emily are fundraising to ensure that, should the worst happen, Elliot has access to further treatment options. They are building a fund that will be available to him over the coming years if needed. 

Their hope, of course, is that Elliot never needs to use this fund. If he doesn’t, the money raised will be donated to Solving Kids’ Cancer UK to support other children facing neuroblastoma. 

As parents, they are committed to doing - and continuing to do - everything within their control for their brave little boy. 

_{Solving Kids' Cancer UK's children's fundraising campaigns 
Funds raised will go towards helping Elliot and his family. If Elliot no longer needs the funds or is in remission seven years post the end of successful treatment, the funds will be used to support other children and families affected by neuroblastoma through our activities. For children with relapsed high-risk neuroblastoma, like Elliot, the survival rate is much lower than other childhood cancers.}